Introduction
Cancer of uterine cervix is the secondmost common cancer affecting women worldwide. One out of every five women in the world suffering from this disease belongs to India.According to the Indian Council of Medical Research (ICMR), the incidence of cervical cancer in India varies from 20 to 35 / 100,000 women between the age group of 35 years to 64 years [1] .
Although cytology screening has resulted in a large reduction in the cervical cancer burden in our country, incidence rates continue to be unabated for want of effective screening programs. More than threefourths of these patients are diagnosed at advanced stages leading to poor prospects of long-term survival and cure. It is well established that invasive cervical carcinomas develop from pre-existing, slowly progressing intraepithelial dysplastic precursor lesions. The direct precursor to invasive squamous carcinoma is a high-grade squamous intraepithelial lesion (HSIL). The object of screening a woman for cervical cancer is to reduce the incidence and mortality by detecting and treating the pre-cancerous lesions.
One of the prerequisites for effective screening is the availability of a suitable cervical screening test that has adequate sensitivity and specificity for detection of precancerous lesions and that yields reproducible results. Such a test should be cheap, simple, and easy to apply, without side effects or complications, as painless as possible, and socioculturally acceptable.
Following its introduction by Papanicoloau in 1927, exfoliativecervicovaginal cytology has been extensively investigated and used as a screening test for cervical cancer. Regular population based screening using Pap smear cytology is now internationally accepted as a screening method for cervical cancer A better understanding of the natural history of cervical cancer and also the increasing evidence for the putative role of the Human Papilloma Virus (HPV) on the epithelium of lower genital tract, and genesis of cervical cancer has now prompted investigators to find alternatives to conventional exfoliative cytology. Colposcopy and HPV DNA testing had become an essential tool in diagnosis of premalignant and malignant lesions of cervix.
Introducing cervical screening programs to areas without them previously results in a 60% to 90% reduction in cervical cancer rates within 3 years [2] . Control of cervical cancer in India would have a major global impact as it accounts for a fifth of the world burden of cervical cancer. The magnitude of the problem due to cervical cancer, and the potential for its prevention, makes it imperative to identify a feasible strategy for screening in the Indian settings.
II. AIM
A. To evaluate the sensitivity and specificity of PAP smear and Colposcopy in screening of premalignant and malignant lesion of cervix. B. To evaluate the usefulness of HPV DNA testing in screening for cervical cancer.
III. Materials And Methods
This is a prospective study conducted in the Department of Obstetrics and Gynecology, Government Coimbatore Medical College from May 2015 to June 2016. The study included 200 randomly selected women who attended our gynecology OPD and fulfilled the inclusion criteria.
Inclusion Criteria: a)
Women of age 20-70 years attending gynecologyOPD with complaints of persistent vaginal discharge, postcoitalbleeding,intermenstrual or perimenopausal bleeding. b) Women with abnormal cervical lesions like cervical hypertrophy, erosion, ulceration, bleeding on touch.
Exclusion Criteria -
Menstruation,Pregnancy,Postpartum,Already treated for cancer cervix,Age <20 and >70years
PAP Smear
Patient was counseled and informed consent was obtained. After relevant social, obstetric, gynecologicaland medical history was obtained, clinical examination was done.
With patient in lithotomy and under illumination, Cusco's self-retaining speculum was introduced into the vagina, cervix visualized and Pap smear was taken with anAyre's spatula rotating 360°around thesquamocolumnar junction, cervical cells were collected and fixed on a slide with isopropyl alcohol.
Colposcopy
With the use of the colposcopy cervix was examined under green filter for abnormal vasculature. 3% acetic acid applied completely and cervix evaluated by meticulous examination of each quadrant of the entire transformation zone. The findings were recorded, followed by application of Lugols iodine findings noted. Colposcopy directed biopsy were taken from abnormal areas with a punch biopsy forceps and sent for HPE.
Detection of HPV infection and genotyping
Seventy randomly selected women from the study underwent HPV DNA testing by PCR. Cervical scarping were collected using a sterile disposable cervical brush in a sample collection buffer(phosphate buffer saline (PBS): pH 7.4) for detection of HPV DNA by PCR. Detection of HPV infection and genotyping was performed by Polymerase Chain Reaction.HPV kit was purchased from Genei,India.This type -specific polymerase chain reaction (TS -PCR)uses two consensus sequence primer pairs within the E6 and E7ORFs to amplify HPV DNA .The PCR products size varying from 230-270bp are subjected to agarose gel electrophoresis and the HPV genotypes are identified based on the base pairs.
IV. Results
This study included a total of randomly selected 200 symptomatic women. The demographic characteristics of the women, according to their age, age at marriage, duration of married life, age at first child birth, parity are described.
The mean age of the study group was 40.6 years. The distributions of premalignant and malignant disease were highest in the women over the age of 40 yrs. Of the 107 women married between the age of 15-19 years 82(76.6%) were normal 25 (23.4%) had Squamous Intraepithelial Lesion or invasive carcinoma. The analysis showed that the women who had the first sexual contact at the age less than 19 years had higher proportion of malignant and premalignant lesion of cervix (23.4%). The women with the age of marriage over 30 years were only 2 and both were normal.
The analysis proved the higher the parity more the proportion of SIL or invasive cancer. The highest proportions of 44.4% were found among the women with parity >5.There was no SIL in the 4 women who were either nulliparous or with one child.
Among the 200 women the commonest complaint was discharge per vaginumof which 23.5% had SIL or invasive CA. Of the women who presented with postcoital bleeding 62.5% had SIL or invasive carcinoma followed by women with post menopausal bleeding (28.6%).
Of the 200 women screened with PAP smear85% had inflammatory smear, 7% had normal cytology and 15% had abnormal cytology. On correlation with HPE of the women who had inflammatory smear on On colposcopic examination 39.5% of the study group had normal colposcopic appearance, erosion was seen in 22.5% ,punctation and Mosaic pattern was seen in 5.5 and 3.5% respectively.Nine (4.5%) of the 200 women had unsatisfactory colposcopy.On application of acetic acid 64 of the women had abnormal colposcopic finding. Premalignant or malignant lesion were found in 47.8% of women with acetowhite area only, 81.6% women with AW area with punctuation and 100% of women with AW area with mosaic pattern. On application of Lugol'siodine44 had negativity of which 65.9% had SIL/Invasive cancer.
Of the 200 colposcopy directed biopsy, 79.5% showed features of cervicitis.LSIL and HSIL were found in 13.5% and 5.5 % of women respectively. Three women showed evidence of invasive cancer.
On correlation with HPE, 79 women with normalcolposcopicappearance, 2.5% had SIL/CA.Among the 45 women with erosion, 2.2%hadSIL/CA. Of the 64 women with abnormal colposcopic finding 39 (60.9%) had SIL/CA.
Of On comparing PAP smear and HPV DNA and correlating with histopathology,20 women who had both cytology and HPV DNA negative had normal or cervicitis in histopathology. Of the 9 women with abnormal cytology and HPV DNAnegative,6 had normal/inflammatory finding in HPE and 3 had SIL. In women with both test positive 3 had normal HPE and 17 had SIL. Among the women with normal cytology and HPV positive, 17 were found to have SIL and 4 had inflammatory histology.
On combining PAP smear and HPV DNA test and correlating with HPE the sensitivity was 100%, specificity was 60.2%. PPV and NPV were 74% and 100% respectively.
V. Discussion
The highest incidence of carcinoma cervix is reported to be seen among the woman in the age group of 35 to 45 years [3] . In our analysis the age wise distribution of SIL or invasive cancer showed a higher incidence among the women in their 4 th or 5 th decade. A similar study done by Pontus Naucler et al showed the cervical cancer peaks at around the age of 40years [4] .
Increased incidence of CIN was found among the women who married at a younger age and hence started early coital activity. Of the women married at the age less than 19 years in the study group 25 (23.4%) had SIL where as in women who married over the age of 25yrs it was 15.4%.
This in all probability appears to be related to the prolonged sexual activity as marriage at an early age is very common in India. It was found in UK by a National study on cervical cancer done by Green et al that the risk of squamous cell carcinoma was strongly related independently to the age at the first intercourse [5] . In our study multiparous women (≥3) contribute to the major proportion of cases with SIL. Xavier Bosch et al reported increased risk of SIL with high parity [6] . In a study done by Hildesheim.A et al42% of HSIL/CA was attributed to multiparity [7] .Green et al noticed that risk of cervical cancer was associated with high parity and the risk increased with early age at the first child birth.
Regarding the complaints most of the women presented with vaginal discharge, of which 25 (23.2%) had SIL. The incidence SIL (62.5%) was highest in women who presented with post coital bleeding which was similar to studies conducted by Shalini et al [8] . The commonest per speculum finding was ectopy of cervix seen in 97 women,of which 27.5% had SIL.
The only screening test which has been universally accepted and has stood the test of time is the Papanicolaou smear test for the early detection of cervical cancer.Modeling of data from South Africa suggests that even screening women just once in their lives, at age 35 could reduce cervical cancer mortality by 26 percent [9] .
In our study PAP smear was taken in all women,of whom 30 (15%) had abnormal cytology. False negative rates were 10.5% in whom the disease was undiagnosed. False positive rates were 5% in whom the disease was over diagnosed.The sensitivity of Pap smear in our study was 48.8%, specificity was 93.7%, PPV was 66.7 % and NPV was 87.6 %. The comparison between our study and other similar studies showed the senisitivity and specificity to be 57.4% and 98.6% by Surendra S Shastri et al, 76% and 97.09% by Ekta Singh et al, 69.2% and 63.7% by katyalsurabi et al, 50% and 78% by AnuradhaKhanna et al, 20% and 91.25% by sukpreeth et al. [10, 11, 12, 13, 14] All women in the study sample underwent colposcopic evaluation , out of the 200 women screened 136 (68 %) had normal colposcopic findings, in the remaining 64 women who had abnormal colposcopic finding 24 (37.5 %) had LSIL, 11 (17.1 %) had HSIL, 3 (4.6 %) had invasive carcinoma the remaining 26 (40.6 %) were false negatives.
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On application of acetic acid 46 women showed aceto white areas without abnormal vascular features, of which 22 (47.8 %) had SIL. 7 women who had aceto white area with mosaic pattern had SIL. 11 women showed punctuations out of which 9 (81.6 %) had SIL.On Application of Lugol's Iodine 44 women were negative and 29 (65.9 %) had SIL, 71 women were partially positive of which 11 (15.4 %) had SIL.
The sensitivity of colposcopy in our study was 92.7 %, specificity was 83.6 %, PPV was 59.4 % and NPV was 97.8 %. Various other studies showed sensitivity and specificity of colposcopy as 100% and 96.4% by katyalSurabi et al,93% and 92.6% by Anuradhakhanna et al, 95% and 63.5% bySukhpreeth Singh et al [12, 13, 14] Colposcopy proved helpful in distinguishing the normal cervix from those with high grade lesion and the results are instant. The colposcopy is an excellent means for follow up of patients with abnormal cytology. It reduces the false negative rates. The colposcopy is used not only in the evaluation of cervix, but the lower female genital tract as the whole. The limitation of colposcopy includes the transformation zone may not be visible fully, needs expertise and time consuming.
70 randomly selected women underwent HPV testing. Out of those 41 were tested to be positive (58.6 %), 29 were tested negative. In our study most common was HPV 16 which is in concordance with study by SilviaFranceschietal [15] and the prevalence of HPV 16 in the study group was 38.5% and HPV 18 was 17.1 %.The sensitivity of HPV testing in our study was 91.8 %, Specificity was 78.8 %, PPV was 82.5 % and NPV was 89.9 % in detecting all grades of SIL. The study by Katyalsurabi et al showed sensitivity and specificity of 92.3% and 84%, which is similar to that this study [12] . Whereas studies by Surendra et al and Samuel et al show sensitivity 62% and 73% and specificity of 93.5% and 62% respectively [10, 16] .
In our study the sensitivity of HPV testing for detecting HSIL and above lesions had a sensitivity of 92.9% and Specificity of 50.8 %.In studies conducted by RengaswamySankarnarayanan et al HPV had a sensitivity of 45.7 -80.9 % and Specificity of 91.7 -94.6 %, Ekta Singh et al had a sensitivity of 90.91 % and Specificity of 51.35 %, Samuel Rathinam et al had a sensitivity of 90 % and Specificity of 51% [16] . The wide variation in sensitivity and Specificity may be due to variation in the quality of sample collection and reference standards [18, 11, 16] .
In our study on combining cytology with HPV testing the sensitivity was raised to 100% and Specificity 60.2 % similar results were shown by Ekta Singh et al sensitivity of 100 % and Specificity of 68.1 %, KatyalSurabi et al had sensitivity of 100 % and Specificity of 61.9 %. [11, 12] HPV DNA test can improve the detection rate of HSIL and also reduce the referral rate by safely allowing the HPV negative woman with equivocal cytology or LSIL to be followed up with cytology at normal intervals.
Any women aged 30 years who had a negative test results on both cytology and HPV DNA should be re screened no more frequently than 3 years. The combined use of these modalities has been shown to increase the sensitivity, but also decrease specificity and increase cost. However it has been estimated that the increase in screening interval will offset the cost of this new screening regime [19] .
VI.
Tables And Figures. 
VII. Conclusion
Screening for cervical cancer remains an important health and economic concern in the throughout the world. All cervical cancer screening programs share challenges in their efforts to educate women about disease prevention and to persuade women to accept screening.
The Pap smear though has been the basis for screening for cervical cancer, has a low sensitivity and a high false negative rates. Colposcopy has a higher sensitivity than PAP smear .It excellent tool in evaluating cervical lesions. The results of colposcopy are immediate and its importance lies in the diagnosis and management of cervical lesions with use of colposcopy.
HPV DNA testing has a higher sensitivity and negative predictive value than PAP smear and it's not influenced by the inflammatory lesion of the vagina. When combinedPAP smear with HPV DNA test, sensitivity and negative predictive value are high. The currently available HPV DNA tests are too expensive and technologically demanding for widespread use, even though their potential for identifying high-grade dysplasia. Hence wherever feasible and affordable HPV DNA test and PAP smear can be combined for better sensitivity. HPV DNA test, due to its high negative predictive value, is used in triage of women with borderline cytology.
Incorporating HPV DNA testing into cervical cancer prevention activities may have to wait for the development of HPV tests that are less expensive than existing options, and easier to use in non-laboratory settings. For the present day, Colposcopy proves to be indispensible method in detecting, evaluating and managing cervical lesion,as long as their limitations are borne in mind.
